Zobrazeno 1 - 10
of 773
pro vyhledávání: '"Xavier Montalban"'
Autor:
Paola Zaratin, Sara Samadzadeh, Meral Seferoğlu, Vito Ricigliano, Jonadab dos Santos Silva, Abdulkadir Tunc, Giampaolo Brichetto, Timothy Coetzee, Anne Helme, Usman Khan, Robert McBurney, Guy Peryer, Helga Weiland, Peer Baneke, Mario Alberto Battaglia, Valerie Block, Luca Capezzuto, Loïc Carment, Paolo Angelo Cortesi, Gary Cutter, Letizia Leocani, Hans-Peter Hartung, Jan Hillert, Jeremy Hobart, Kaisa Immonen, Paul Kamudoni, Rod Middleton, Patricia Moghames, Xavier Montalban, Liesbet Peeters, Maria Pia Sormani, Susanna van Tonder, Angela White, Giancarlo Comi, Patrick Vermersch
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
Significant advancements have been achieved in delineating the progress of the Global PROMS (PROMS) Initiative. The PROMS Initiative, a collaborative endeavor by the European Charcot Foundation and the Multiple Sclerosis International Federation, str
Externí odkaz:
https://doaj.org/article/71f586d1f32749e380954d0f3ed8f667
Autor:
Jiwon Oh, Luca Capezzuto, Lito Kriara, Jens Schjodt-Eriksen, Johan van Beek, Corrado Bernasconi, Xavier Montalban, Helmut Butzkueven, Ludwig Kappos, Gavin Giovannoni, Riley Bove, Laura Julian, Mike Baker, Christian Gossens, Michael Lindemann
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Floodlight Open was a global, open-access, digital-only study designed to understand the drivers and barriers in deployment and use of a smartphone app in a naturalistic setting and broad study population of people with and without multiple
Externí odkaz:
https://doaj.org/article/63fe8ec56ad740f388dff117b0187330
Autor:
Sunny Malhotra, Nicolas Fissolo, Carmen Rodríguez‐Rivera, Enric Monreal, Marta Montpeyo, Elena Urcelay, Juan Carlos Triviño, María José Pérez‐García, Miguel F. Segura, Agustín Pappolla, Jordi Río, Andreu Vilaseca, José Ignacio Fernández Velasco, Andrés Miguez, Carlos Goicoechea, Marta Martinez‐Vicente, Luisa M Villar, Xavier Montalban, Manuel Comabella
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 4, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/c4c6c2fc280e4866a272562127ef32f3
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 12, p 6732 (2024)
Multiple sclerosis (MS) onset at an advanced age is associated with a higher risk of developing progressive forms and a greater accumulation of disability for which there are currently no effective disease-modifying treatments. Immunosenescence is as
Externí odkaz:
https://doaj.org/article/e822b97808eb4a9fa5d2f0525100b2e4
Autor:
Xavier Montalban, Paul M. Matthews, Alex Simpson, John L. Petrie, Cormac Sammon, Sreeram Ramagopalan, Giulio Disanto, Jens Kuhle
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 10, Iss 3, Pp 302-311 (2023)
Abstract Across its clinical development program, ocrelizumab demonstrated efficacy in improving clinical outcomes in multiple sclerosis, including annualized relapse rates and confirmed disability progression. However, as with any new treatment, it
Externí odkaz:
https://doaj.org/article/08ac64793ae54653927c1160ce2c1112
Assessment of Upper Extremity Function in Multiple Sclerosis: Feasibility of a Digital Pinching Test
Autor:
Jennifer S Graves, Marcin Elantkowski, Yan-Ping Zhang, Frank Dondelinger, Florian Lipsmeier, Corrado Bernasconi, Xavier Montalban, Luciana Midaglia, Michael Lindemann
Publikováno v:
JMIR Formative Research, Vol 7, p e46521 (2023)
BackgroundThe development of touchscreen-based assessments of upper extremity function could benefit people with multiple sclerosis (MS) by allowing convenient, quantitative assessment of their condition. The Pinching Test forms a part of the Floodli
Externí odkaz:
https://doaj.org/article/128fc2e6b1654d6c8f07e2a05c69ac41
Autor:
Alasdair J. Coles, Anat Achiron, Anthony Traboulsee, Barry A. Singer, Carlo Pozzilli, Celia Oreja-Guevara, Gavin Giovannoni, Giancarlo Comi, Mark S. Freedman, Tjalf Ziemssen, Debora Shiota, Andreea M. Rawlings, Alana T. Wong, Magdalena Chirieac, Xavier Montalban
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 16 (2023)
Background and objectives: Alemtuzumab demonstrated superior efficacy versus subcutaneous interferon (IFN) beta-1a in participants with relapsing-remitting multiple sclerosis in the 2-year CARE-MS I and II trials. Efficacy was maintained in the 4-yea
Externí odkaz:
https://doaj.org/article/d1ccbb1ea3314b49a9e39f7237862350
Autor:
Jennifer S. Graves, Marco Ganzetti, Frank Dondelinger, Florian Lipsmeier, Shibeshih Belachew, Corrado Bernasconi, Xavier Montalban, Johan vanBeek, Michael Baker, Christian Gossens, Michael Lindemann
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 10, Iss 2, Pp 166-180 (2023)
Abstract Objective To validate the smartphone sensor‐based Draw a Shape Test – a part of the Floodlight Proof‐of‐Concept app for remotely assessing multiple sclerosis‐related upper extremity impairment by tracing six different shapes. Metho
Externí odkaz:
https://doaj.org/article/95744f757b8d45baa7eaa90ba0d469d1
Autor:
Elias S. Sotirchos, Kathryn C. Fitzgerald, Carol M. Singh, Matthew D. Smith, Maria Reyes‐Mantilla, Carrie M. Hersh, Megan H. Hyland, Ryan Canissario, Sarah B. Simmons, Georgina Arrambide, Xavier Montalban, Manuel Comabella, Robert T. Naismith, Min Qiao, Lauren B. Krupp, Jacqueline A. Nicholas, Katja Akgün, Tjalf Ziemssen, Richard Rudick, Elizabeth Fisher, Robert A. Bermel, Ellen M. Mowry, Peter A. Calabresi
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 10, Iss 1, Pp 84-97 (2023)
Abstract Objective Evaluation of serum neurofilament light chain (sNfL), measured using high‐throughput assays on widely accessible platforms in large, real‐world MS populations, is a critical step for sNfL to be utilized in clinical practice. Me
Externí odkaz:
https://doaj.org/article/af7dafcddd2344fa8cf6fe2ae367d591
Autor:
Nicolas Fissolo, Laura Calvo-Barreiro, Herena Eixarch, Ursula Boschert, Luisa M. Villar, Lucienne Costa-Frossard, Mireia Ferrer, Alex Sanchez, Eva Borràs, Eduard Sabidó, Carmen Espejo, Xavier Montalban, Manuel Comabella
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionLittle is known about the molecular profiling associated with the effect of cladribine in patients with multiple sclerosis (MS). Here, we aimed first to characterize the transcriptomic and proteomic profiles induced by cladribine in blood
Externí odkaz:
https://doaj.org/article/9035da7161674ce99a2b2cd80d00a33e